Startup India Government of India
Recombinant Dna Biosciences Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.6 Cr
▲ 42% YoY
Net profit · FY 2024
₹3.53 Lakh
Net margin 2.2%
EBITDA · FY 2024
₹5.1 Lakh
EBITDA margin 3.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
About Recombinant Dna Biosciences Private Limited
Data last updated:
Recombinant Dna Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 20 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC309441. Its GSTIN is 07AAICR1468C1ZH (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kaushlesh Singh and Piyoosh Mishra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Tc – 681 Ground Floor Raghubir Nagar, New Delhi, Delhi, India – 110027.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.6 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹3.53 Lakh (net margin 2.2%) and EBITDA of ₹5.1 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 313% over five years.
As per MCA filings, the company has open charges of ₹75 Lakh on record.
Recombinant Dna Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0005217). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rdbpl.co.in.
Company details
CIN U74999DL2016PTC309441
Registration Number 309441
Incorporation Date 20 December 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0005217
Recognitions & Rankings of Recombinant Dna Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0005217
Contact details
Recombinant Dna Biosciences Private Limited's registered office is in New Delhi, Delhi. Its website is rdbpl.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressTc – 681 Ground Floor Raghubir Nagar, New Delhi, Delhi, India – 110027
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Recombinant Dna Biosciences Private Limited, buy the company report.
Comprehensive company report
Recombinant Dna Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Recombinant Dna Biosciences is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Recombinant Dna Biosciences Private Limited, buy the company report.
Financials of Recombinant Dna Biosciences Private Limited
FY 2024 filings availableRecombinant Dna Biosciences Private Limited reported revenue of ₹1.6 Cr (up 42% YoY) for FY 2024.
Revenue · FY 2024
₹1.6 Cr ▲ 42%
Net profit · FY 2024
₹3.53 Lakh margin 2.2%
EBITDA · FY 2024
₹5.1 Lakh margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▼ 11%
5 years · compounded
▲ 313%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▼ 22%
5 years · compounded
▲ 128%
Revenue has grown at a compounded annual rate (CAGR) of 313% over five years, including 42% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Recombinant Dna Biosciences Private Limited, buy the company report.
Board of directors of Recombinant Dna Biosciences Private Limited
Recombinant Dna Biosciences has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaushlesh Singh | Director | 30 Jan 2024 | 2 Years 9 Months | Current |
| Piyoosh Mishra | Director | 13 Oct 2017 | 9 Years 0 Months | Current |
| Raju Jaiswal | Director | 13 Oct 2017 | 9 Years 0 Months | Current |
| Chandra Kant Maheshwari | Director | 26 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Recombinant Dna Biosciences Private Limited is audited by SACHDEVA BAGGA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SACHDEVA BAGGA & ASSOCIATES | FY 2023 | 0017557N |
Shareholding
The shareholding of Recombinant Dna Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Recombinant Dna Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹75 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2025 | 101185993 | Hdfc Bank Limited | ₹75 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Recombinant Dna Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Recombinant Dna Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Recombinant Dna Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICR1468C1ZH | Delhi | Active | 26 Feb 2019 |
To see the full GST registrations and return filing status of Recombinant Dna Biosciences Private Limited, buy the company report.
Recent activity
Recombinant Dna Biosciences Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: Kaushlesh Singh ceased to be Additional Director on 29 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 101185993 was registered on 13 Oct 2025.
AGM
Recombinant Dna Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Kaushlesh Singh ceased to be Additional Director.
Filing
Recombinant Dna Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Kaushlesh Singh was appointed as Director.
Appointed
Chandra Kant Maheshwari was appointed as Director.
Ceased
Rakesh Khurana ceased to be Director.
Ceased
Yogendra Kumar ceased to be Director.
Appointed
Piyoosh Mishra was appointed as Director.
Appointed
Raju Jaiswal was appointed as Director.
Incorporation
20 Dec 2016
Recombinant Dna Biosciences Private Limited was registered on 20 Dec 2016 with Roc Delhi & aged 9 years 10 months as per MCA records.
Frequently asked questions
Recombinant Dna Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 20 December 2016 (10+ years old) and is registered under CIN U74999DL2016PTC309441.
Recombinant Dna Biosciences has 4 current directors:
- Kaushlesh Singh - Director
- Piyoosh Mishra - Director
- Raju Jaiswal - Director
- Chandra Kant Maheshwari - Director
The latest financial statements of Recombinant Dna Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Recombinant Dna Biosciences is 07AAICR1468C1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Recombinant Dna Biosciences is U74999DL2016PTC309441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Recombinant Dna Biosciences was incorporated on 20 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Kaushlesh Singh ceased to be Additional Director on 29 Sep 2024. Kaushlesh Singh was appointed as Director on 30 Jan 2024. Chandra Kant Maheshwari was appointed as Director on 26 Jan 2019. Recombinant Dna Biosciences has 7 board changes on record in total.
Yes, Recombinant Dna Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Recombinant Dna Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0005217).
Recombinant Dna Biosciences can be reached through the website rdbpl.co.in. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages